These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15090935)

  • 1. Long-term evaluation of the effect of quetiapine on hallucinations, delusions and motor function in advanced Parkinson disease.
    Mancini F; Tassorelli C; Martignoni E; Moglia A; Nappi G; Cristina S; Pacchetti C
    Clin Neuropharmacol; 2004; 27(1):33-7. PubMed ID: 15090935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
    Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
    Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
    Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis.
    Morgante L; Epifanio A; Spina E; Zappia M; Di Rosa AE; Marconi R; Basile G; Di Raimondo G; La Spina P; Quattrone A
    Clin Neuropharmacol; 2004; 27(4):153-6. PubMed ID: 15319699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
    Merims D; Balas M; Peretz C; Shabtai H; Giladi N
    Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of quetiapine in Parkinson's patients with psychosis.
    Targum SD; Abbott JL
    J Clin Psychopharmacol; 2000 Feb; 20(1):54-60. PubMed ID: 10653209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Threatening auditory hallucinations and Cotard syndrome in Parkinson disease.
    Factor SA; Molho ES
    Clin Neuropharmacol; 2004; 27(5):205-7. PubMed ID: 15602098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Fernandez HH; Friedman JH; Jacques C; Rosenfeld M
    Mov Disord; 1999 May; 14(3):484-7. PubMed ID: 10348474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study.
    Katzenschlager R; Manson AJ; Evans A; Watt H; Lees AJ
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):295-7. PubMed ID: 14742609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S; Factor SA; Molho ES; Feustel PJ
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine for insomnia in Parkinson disease: results from an open-label trial.
    Juri C; Chaná P; Tapia J; Kunstmann C; Parrao T
    Clin Neuropharmacol; 2005; 28(4):185-7. PubMed ID: 16062098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual hallucinations in PD.
    Frucht SJ; Bernsohn L
    Neurology; 2002 Dec; 59(12):1965. PubMed ID: 12499491
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
    Friedman JH; Factor SA
    Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.
    Fernandez HH; Trieschmann ME; Burke MA; Friedman JH
    J Clin Psychiatry; 2002 Jun; 63(6):513-5. PubMed ID: 12088163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis].
    Kodama R; Morita S; Miwa H; Kondo T
    No To Shinkei; 2003 May; 55(5):413-7. PubMed ID: 12833883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimavanserin approved for Parkinson's-related hallucinations, delusions.
    Traynor K
    Am J Health Syst Pharm; 2016 Jun; 73(12):853. PubMed ID: 27261226
    [No Abstract]   [Full Text] [Related]  

  • 18. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
    Friedman JH
    J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of olanzapine for delusion in patients with Parkinson's disease].
    Ito M; Atsuta N; Watanabe H; Hirayama M; Sobue G
    No To Shinkei; 2005 Jun; 57(6):491-4. PubMed ID: 16026044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease].
    Giménez-Roldán S; Navarro E; Mateo D
    Rev Neurol; 2003 Mar 1-15; 36(5):401-4. PubMed ID: 12640589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.